- £4.09bn
- £5.25bn
- £276.10m
- 44
- 22
- 82
- 45
2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 156 | 216 | 267 | 259 | 276 |
Cost of Revenue | |||||
Gross Profit | 123 | 162 | 203 | 189 | 199 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 327 | 243 | 10.2 | 21.3 | 157 |
Operating Profit | -171 | -27.5 | 257 | 238 | 119 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -101 | -120 | 343 | 352 | 103 |
Provision for Income Taxes | |||||
Net Income After Taxes | -87.6 | -122 | 345 | 352 | 104 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -89.2 | -121 | 342 | 351 | 103 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -89.2 | -121 | 342 | 351 | 103 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.62 | -0.302 | 0.857 | 0.876 | 0.246 |
Dividends per Share |